Why Melasma Comes Back — and What Control Looks Like

Melasma does not get cured, and a clinic telling you otherwise has either misdiagnosed it or is describing the first eight weeks of a longer story. It is a chronic relapsing condition, and heat triggers it as reliably as sunlight does. Understanding that changes what treatment is for — and explains why the most aggressive approach is consistently the one that fails.

A Condition, Not A Stain

The mental model most patients bring is that melasma is a deposit sitting in the skin, and that a sufficiently powerful device will remove it. That model predicts that stronger treatment produces better clearance, and it is the reason so many patients arrive having been treated progressively harder with progressively worse results.

What is actually present is a population of melanocytes that have become chronically overactive, sitting on a basement membrane that has been disrupted so that pigment drops into the dermis below, where melanophages hold it. There is usually an increased vascular component beneath the patch as well, and often a degree of chronic low-grade inflammation.

That is a functional disorder of cells that are still there and still responsive, not a passive deposit. Remove the pigment they have made and they will make more, and the trigger that makes them do so is frequently the treatment itself. Melasma behaves like an inflammatory skin condition with a pigmentary expression, and it is managed like one.

Heat Is A Trigger, Not Only Light

Ultraviolet radiation is the trigger everyone knows about. Visible light — particularly the blue-violet end, which passes straight through conventional transparent sunscreen — is a second and largely unguarded one. The third is infrared and simple conducted heat, and it is the one that catches patients who are otherwise doing everything correctly.

In practical Singaporean terms that means hot yoga, steam rooms, saunas, standing over a wok, a long motorcycle commute in the sun, and hot-towel or steam-based facials. Patients whose melasma darkens every time they cook, or who noticed a flare after a spa treatment, have usually observed a real association rather than a coincidence.

The mechanism is the same in each case: heat increases blood flow in the dermal vasculature beneath the patch and stimulates the melanocytes above it. It does not require a visible burn or any discomfort. Warmth sustained over time is sufficient, which is precisely why heat-based devices are used with such care on melasma-prone skin.

Why Aggressive Treatment Makes It Worse

Rebound is the defining behaviour of this condition and the single most useful thing a patient can understand about it. Aggressive laser, deep chemical peeling or high-energy radiofrequency applied to melasma frequently produces a genuinely good result at two to three weeks, as the existing pigment clears. The pigment then returns at six to ten weeks, darker and often broader than the original patch.

This is not treatment failure in the ordinary sense. It is the expected physiological response of a hyperactive melanocyte population to thermal injury — inflammation, followed by upregulated pigment production. The early improvement is real and the later worsening is equally real, and judging the treatment at the two-week mark is what keeps the cycle going.

The clinical consequence is that melasma is treated with deliberately restrained energy. Low-fluence laser toning suppresses melanocyte activity without crossing the injury threshold, and progress is judged over months rather than weeks. The physics of that choice is set out in laser toning versus pico.

Photoprotection That Accounts For Visible Light

Singapore sits close to the equator with high ultraviolet index readings through the year and no seasonal relief. There is no winter in which pigment quietly settles, and there is no cloudy month that permits a lapse. Photoprotection in this condition is a daily structural commitment rather than a holiday behaviour.

Conventional transparent sunscreen filters ultraviolet and passes visible light. Tinted formulations containing iron oxides block a meaningful portion of the visible spectrum, which is why they are specified for melasma rather than treated as a cosmetic preference. The tint is the active element, not the packaging.

Reapplication matters more than the number on the bottle, and physical shade matters more than either. A wide-brimmed hat during the midday walk between buildings does more than upgrading a sunscreen by a few points. Patients who improve and then relapse every December have usually found the gap in their own routine without recognising it.

Hormonal And Medication Triggers

Pregnancy is a common trigger, and melasma that appears during pregnancy sometimes fades in the months following delivery and sometimes does not. Combined oral contraceptives and hormone replacement can initiate or sustain it. Thyroid dysfunction has a recognised association and is worth excluding where the presentation is atypical or abruptly worse.

None of this makes treatment futile, but it does change what is realistic. Active treatment against a sustained hormonal driver is a holding action, and the honest conversation includes the option of reviewing the contraceptive method with the prescribing doctor, which is a decision for the patient and their own physician rather than for an aesthetic clinic.

Certain photosensitising medications also contribute. Where melasma worsens abruptly without a change in sun exposure, a medication review is a more useful next step than a stronger laser setting. Diagnosis remains the first task even in a condition the patient has already been told they have.

What Control Actually Looks Like

Control means the patch is substantially lighter, stable across months, and no longer the first thing the patient sees in the mirror. It does not mean the skin returns to a state in which melasma was never present. Melanocytes that have behaved this way remain capable of behaving this way, and management is built on that assumption rather than against it.

In practice that is a combination: topical regulation of melanocyte activity used consistently rather than in bursts, low-energy suppression delivered as a course, treatment of any significant vascular component, strict photoprotection, and heat avoidance. Gentler adjunctive work such as Rejuran or low-downtime brightening with the R2 Glow protocol supports the skin rather than challenging it.

Maintenance is not an upsell, it is the structure of the treatment. Patients who stop entirely once they are pleased with the result generally relapse within months, and relapse is harder to treat than the original patch. The goal, stated plainly at the outset, is long-term control — and stating it plainly is what makes the result satisfying rather than disappointing.

When It Is Not Melasma At All

Symmetrical brown patches on the cheeks have a differential. Post-inflammatory hyperpigmentation from acne, eczema or prior treatment can mimic it closely, and it behaves differently and clears more completely — the distinction is drawn in post-inflammatory hyperpigmentation.

Dermal melanocytosis, drug-induced pigmentation, lichen planus pigmentosus and photosensitive dermatoses all sit in the same visual territory and respond to different management. Where a patch is unilateral, sharply demarcated, unusually distributed, or genuinely unresponsive to correct treatment, the diagnosis deserves revisiting rather than the settings.

Some of these belong with a dermatologist rather than in an aesthetic clinic, and saying so is part of the assessment. The general framework for sorting them is set out in the assessment of facial pigmentation; the point of it is to be certain what is being treated before committing a patient to a year of treatment for it.